AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2015

Jun 26, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2015-06-23

Reporting Person: Ho Maykin (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-23	Stock Option (right to buy)	$103.63	A	21250	Acquired	2025-06-22	Common stock (21250)	Direct

Footnotes

F1: This option was granted on June 23, 2015. The shares underlying this option vest as to 25% of the underlying shares on June 23, 2016, with the remaining 75% vesting in 36 equal monthly installments thereafter.